Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-08T05:00:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T01:45:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T18:11:04.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new identifiers and indications for a clinical study involving rare cancers, while significant details about the study's design and eligibility criteria have been removed.
    Difference
    24%
    Check dated 2025-04-16T14:09:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T08:45:11.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:04:04.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.